DiaTribe | Making Sense Of Diabetes
diaTribe provides free cutting-edge diabetes insights and actionable tips for people with diabetes. Our mission is to help individuals better understand their diabetes and to make our readers happier and healthier.
Actived: Friday Feb 19, 2021
Visit Site: https://diatribe.org/
Inside Rx: Discounts Available for Insulin and Other
The discounts seem to be greater for insulin products (mostly in the 40%-50% range) than for diabetes pills (around 20%-30% off). See below for a full list of diabetes medications currently available for discounted purchase with an Inside Rx card (including Jardiance, Tradjenta, and Onglyza).
The Hidden Costs of Discount Cards: Understanding Copay
When coupons make drugs affordable to consumers, manufacturers are given room to raise prices without impacting demand. Ultimately, insurers pay the difference. A 2016 study found that among 23 brand name medications for which there was a generic equivalent available, coupons increased overall spending by an average of between $6 million to $24
How Can I Pay for Diabetes Medications and Care? | diaTribe
The trade-off is that there will likely be higher out-of-pocket costs for out-of-network services. An EPO (Exclusive Provider Organization) offers lower premiums (monthly fees) and out-of-pocket costs, as well as direct access to specialists without a referral.
FreeStyle Libre Now Available in Major US Pharmacies
By Amelia Dmowska and Adam Brown. Abbott’s no-calibration CGM available at pharmacies like CVS and Walgreens for a cash price ranging from about $36-$53/ 10-day sensor; g et cost and prescription details here. Want more news just like this? Sign Up Now! Two months after approval by the Food and Drug Administration (FDA), Abbott’s FreeStyle Libre (real time) continuous glucose monitor (CGM
In a Race for a New and Cheaper Insulin Glargine, Legal
Do you ever wonder why there aren’t cheaper “generic” insulin products available? This may soon change as the patents for branded insulin begin to expire. In fact, the patents for Sanofi’s top-selling Lantus (basal insulin glargine) are set to expire in the US in 2015, and other companies are racing to produce new “generic” insulins that could provide more choices for patients
FDA Approves Novo Nordisk’s Saxenda as a Treatment for
Twitter summary: FDA approves Novo Nordisk’s chronic weight management drug Saxenda, another option to help treat #obesity On December 23, the FDA approved Novo Nordisk’s Saxenda (liraglutide injection) as a treatment option for weight management, to be taken in addition to a reduced-calorie diet and physical activity. The drug is approved for use in people with a body mass
Ultra Rapid-Acting Inhaled Insulin Afrezza Now Available
Twitter Summary: Sanofi + MannKind Afrezza now available in some US pharmacies; prices comparable to Novolog/Humalog, @afrezzauser gives patient perspective! Update (2/3/15): Today, Sanofi and MannKind announced the official launch of the ultra rapid-acting inhaled-insulin Afrezza. The insulin is now available at pharmacies nationwide.
Scan FreeStyle Libre CGM Sensor with Your iPhone
By Jimmy McDermott and Maeve Serino FreeStyle LibreLink app allows FreeStyle Libre users in the US to obtain a real-time glucose reading directly on their iPhone. Plus, LibreLinkUp now available for caregivers to remotely monitor glucose and trends Editor's Note: This article was updated on April 16th, 2019 with the availability of LibreLinkUp in the US.